474 related articles for article (PubMed ID: 26973130)
1. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?
Mandviwala T; Khalid U; Deswal A
Curr Atheroscler Rep; 2016 May; 18(5):21. PubMed ID: 26973130
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Obesity on the Cardiovascular System.
Csige I; Ujvárosy D; Szabó Z; Lőrincz I; Paragh G; Harangi M; Somodi S
J Diabetes Res; 2018; 2018():3407306. PubMed ID: 30525052
[TBL] [Abstract][Full Text] [Related]
3. Impact of obesity on cardiovascular disease.
Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
[TBL] [Abstract][Full Text] [Related]
4. The relationship between obesity and coronary artery disease.
Jahangir E; De Schutter A; Lavie CJ
Transl Res; 2014 Oct; 164(4):336-44. PubMed ID: 24726461
[TBL] [Abstract][Full Text] [Related]
5. Overweight and grade I obesity in patients with cardiovascular disease: to treat or not to treat?
Haberka M; Stolarz-Skrzypek K; Czarnecka D; Gąsior Z; Olszanecka-Glinianowicz M
Pol Arch Med Wewn; 2014; 124(12):731-9. PubMed ID: 25354500
[TBL] [Abstract][Full Text] [Related]
6. Obesity and cardiovascular diseases.
Kachur S; Lavie CJ; de Schutter A; Milani RV; Ventura HO
Minerva Med; 2017 Jun; 108(3):212-228. PubMed ID: 28150485
[TBL] [Abstract][Full Text] [Related]
7. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
[TBL] [Abstract][Full Text] [Related]
8. [Obesity and the prognosis of heart failure: the obesity paradox, myth or reality?].
Bounhoure JP; Galinier M; Roncalli J; Massabuau P
Bull Acad Natl Med; 2014 Jan; 198(1):61-9; discussion 69-70. PubMed ID: 26259287
[TBL] [Abstract][Full Text] [Related]
9. Impact of obesity on cardiac metabolism, fibrosis, and function.
Mahajan R; Lau DH; Sanders P
Trends Cardiovasc Med; 2015 Feb; 25(2):119-26. PubMed ID: 25446049
[TBL] [Abstract][Full Text] [Related]
10. [Obesity as a risk factor for atrial fibrillation].
Duraj I; Broncel M
Pol Merkur Lekarski; 2016 Jan; 40(235):5-8. PubMed ID: 26891428
[TBL] [Abstract][Full Text] [Related]
11. Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients?
Roberts AW; Clark AL; Witte KK
Diab Vasc Dis Res; 2009 Jul; 6(3):153-63. PubMed ID: 20368207
[TBL] [Abstract][Full Text] [Related]
12. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links.
Goudis CA; Korantzopoulos P; Ntalas IV; Kallergis EM; Ketikoglou DG
J Cardiol; 2015 Nov; 66(5):361-9. PubMed ID: 25959929
[TBL] [Abstract][Full Text] [Related]
13. Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.
da Silva RM
Curr Atheroscler Rep; 2017 Jan; 19(1):2. PubMed ID: 28102478
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia as a risk factor for cardiovascular disease: clinical review.
Gudiño Gomezjurado Á
Medwave; 2016 Nov; 16(10):e6606. PubMed ID: 27922586
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats.
Hohl M; Lau DH; Müller A; Elliott AD; Linz B; Mahajan R; Hendriks JML; Böhm M; Schotten U; Sanders P; Linz D
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28919580
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin and cardiovascular disease: State-of-the-art review.
Arques S
Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):192-200. PubMed ID: 32797938
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity on the risk of heart failure and its prognosis.
Artham SM; Lavie CJ; Patel HM; Ventura HO
J Cardiometab Syndr; 2008; 3(3):155-61. PubMed ID: 18983332
[TBL] [Abstract][Full Text] [Related]
18. Gender and geographic differences in CAD risk factors and CHADS2 scores in atrial fibrillation patients.
Bhardwaj R; Sharma P; Finkel MS; Jain S; Arham A; Kazmi T; Beto RJ; Gharib W; Warden BE; Jain AC
W V Med J; 2012; 108(1):18-21. PubMed ID: 25134188
[TBL] [Abstract][Full Text] [Related]
19. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A; Galar M
Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular complications of cancers and anti-cancer therapy].
Vyskočil J; Petráková K; Jelínek P; Furdek M
Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
